1,721,006 research outputs found
sj-pdf-2-cep-10.1177_03331024231156922 - Supplemental material for Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis
No full textSupplemental material, sj-pdf-2-cep-10.1177_03331024231156922 for Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis by Samita Giri, Erling Tronvik, Mattias Linde, Sindre Andre Pedersen and Knut Hagen in Cephalalgia</p
sj-pdf-1-cep-10.1177_03331024231156922 - Supplemental material for Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis
No full textSupplemental material, sj-pdf-1-cep-10.1177_03331024231156922 for Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis by Samita Giri, Erling Tronvik, Mattias Linde, Sindre Andre Pedersen and Knut Hagen in Cephalalgia</p
Supplemental Material, sj-docx-1-rep-10.1177_25158163221075569 - Epidemiology of diagnosed cluster headache in Norway
No full textSupplemental Material, sj-docx-1-rep-10.1177_25158163221075569 for Epidemiology of diagnosed cluster headache in Norway by Joan Crespi, Sasha Gulati, Øyvind Salvesen, Daniel Fossum Bratbak, David W Dodick, Manjit Singh Matharu and Erling Tronvik in Cephalalgia Reports</p
Supplemental Material, sj-docx-2-rep-10.1177_25158163221075569 - Epidemiology of diagnosed cluster headache in Norway
No full textSupplemental Material, sj-docx-2-rep-10.1177_25158163221075569 for Epidemiology of diagnosed cluster headache in Norway by Joan Crespi, Sasha Gulati, Øyvind Salvesen, Daniel Fossum Bratbak, David W Dodick, Manjit Singh Matharu and Erling Tronvik in Cephalalgia Reports</p
sj-pdf-5-cep-10.1177_03331024231187132 - Supplemental material for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
No full textSupplemental material, sj-pdf-5-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia</p
sj-pdf-4-cep-10.1177_03331024231187132 - Supplemental material for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
No full textSupplemental material, sj-pdf-4-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia</p
sj-pdf-1-cep-10.1177_03331024231187132 - Supplemental material for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
No full textSupplemental material, sj-pdf-1-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia</p
sj-pdf-2-cep-10.1177_03331024231187132 - Supplemental material for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
No full textSupplemental material, sj-pdf-2-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia</p
sj-pdf-3-cep-10.1177_03331024231187132 - Supplemental material for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study
No full textSupplemental material, sj-pdf-3-cep-10.1177_03331024231187132 for Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study by Kent A. Jamtøy, Wenche M. Thorstensen, Lars J. Stovner, Annika Rosén, Stine Maarbjerg, Daniel Bratbak, Melanie R. Simpson and Erling Tronvik in Cephalalgia</p
sj-pdf-1-cep-10.1177_03331024211056565 - Supplemental material for Pain thresholds and suprathreshold pain after sleep restriction in migraine – A blinded crossover study
No full textSupplemental material, sj-pdf-1-cep-10.1177_03331024211056565 for Pain thresholds and suprathreshold pain after sleep restriction in migraine – A blinded crossover study by Jan Petter Neverdahl, Martin Uglem, Dagfinn Matre, Johannes Orvin Hansen, Morten Engstrøm, Erling Tronvik, Lars Jacob Stovner, Trond Sand and Petter Moe Omland in Cephalalgia</p
- …
